Chiome Bioscience Inc. and Chugai Pharmaceutical Co. Ltd. (Chugai) have agreed with extension of the Master Services Agreement. The Master Services Agreement was originally signed as of June 30, 2011 to provide Chiome's service to support Chugai. This amendment herein extends the contract period. Any information relating to this Agreement that requires disclosure will be announced in a timely manner in the future. There is no impact on the financial performance in the fiscal period ending December 31, 2024.